A new antiviral assay has been developed that could allow for the detection the Zika virus in infected cell cultures.
Southern Research (AL, USA) recently announced the unique antiviral assay and state that it is available immediately for use by international clients. In addition to the assay, the researchers are also working on in vivo models that may be used to investigate vaccines and other therapeutic approaches for targeting the Zika virus.
Zika is a mosquito-borne virus that is believed to cause microcephaly and other brain defects in newborns if transmitted to mothers in the early stages of pregnancy.
The Zika virus was initially reported in Brazil and other regions of South and Central America; however in recent weeks and months several new cases have been reported across the world. The World Health Organization has declared the spread of Zika a Public Health Emergency demanding a global response.
Jonathan Rayner, Director of Infectious Disease Research at Southern Research, commented, “Southern Research is uniquely positioned to support the efforts of the global scientific community as we work collectively to better understand, and ultimately stop the spread of this disease. This assay represents a crucial step in the global search for a vaccine, and we’re proud to be able to contribute to the growing body of science in this impactful way.”
Source: Southern Research press release